Karyopharm Therapeutics Inc. (KPTI) Social Stream



Karyopharm Therapeutics Inc. (KPTI): $6.52

0.26 (+4.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Karyopharm Therapeutics Inc (KPTI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering KPTI.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
9 $29 $6 $15.22 $6.31 141.2%

The Trend in the Analyst Price Target


Over the past 41 weeks, KPTI's average price target has gone down $15.78.

KPTI reports an average of 157.23% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-19 9 29 6 15.22 6.070 150.74%
2021-09-18 9 29 6 15.22 6.070 150.74%
2021-09-11 9 29 6 15.22 5.790 162.87%
2021-08-17 9 29 6 15.22 4.850 213.81%
2021-08-14 9 29 6 15.22 4.880 211.89%
2021-08-07 9 29 6 16.67 5.520 201.99%
2021-08-05 9 49 11 24.89 5.930 319.73%
2021-08-01 9 49 11 24.89 8.330 198.8%
2021-07-24 9 49 11 24.89 8.840 181.56%
2021-06-28 9 49 11 25.11 10.700 134.67%
2021-06-26 9 49 11 25.11 10.990 128.48%
2021-06-13 9 49 11 25.11 10.320 143.31%
2021-05-03 9 49 21 30.00 9.440 217.8%
2021-04-25 9 49 21 30.00 9.390 219.49%
2021-04-12 9 49 21 30.00 9.960 201.2%
2021-04-10 9 49 21 30.00 10.020 199.4%
2021-04-03 9 49 21 30.00 10.840 176.75%
2021-03-20 9 49 21 30.00 12.060 148.76%
2021-02-15 9 49 21 30.00 15.220 97.11%
2021-02-13 9 49 21 30.00 15.220 97.11%
2021-02-06 9 49 22 31.44 16.175 94.37%
2021-01-30 9 49 22 32.00 15.230 110.11%
2021-01-23 9 49 22 32.00 15.090 112.06%
2020-12-09 9 41 21 31.00 15.390 101.43%
2020-12-07 9 41 21 31.00 15.530 99.61%
2020-11-28 9 41 21 31.00 15.140 104.76%
2020-11-03 10 41 21 31.60 14.240 121.91%
2020-10-18 10 41 20 31.90 15.800 101.9%
2020-09-05 10 41 20 32.00 NA NA%
2020-08-04 10 41 20 32.00 NA NA%
2020-07-19 10 41 26 33.00 NA NA%
2020-07-02 10 41 26 33.00 NA NA%
2020-06-22 9 41 26 32.89 NA NA%
2020-05-13 9 40 25 31.33 NA NA%

KPTI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.6 3 3 3 0 0 10

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The variance in analysts' estimates of KPTI is lower than 1.06999999999999% of all US stocks.
  • Karyopharm Therapeutics Inc's number of analysts covering the stock is greater than 96.78% of stocks in the small market cap category.
  • KPTI has a higher upside potential (average analyst target price relative to current price) than 87.06% of all US stocks.
  • KPTI has a greater average analyst price target than 29.34% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Karyopharm Therapeutics Inc are CCXI, PRVB and IMGN.

Make investment decisions regarding KPTI using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8556 seconds.